Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric Cancer.

Journal of gastric cancer - 1 Apr 2026

Moon Ye Jin, Kwon Woo Sun, Park Chan Hee, Jang Jinsoo, Park Juin, Yoon Byeong Gyu, Mun Han Byeol, Kim Namju, Lee Choong-Kun, Jeung Hei Cheul, Shin Su-Jin, Kim Tae Soo, Rha Sun Young

Abstract excerpt

PURPOSE: Patient-derived cells (PDCs) and patient-derived organoids (PDOs) are complementary preclinical models widely used in translational cancer research. However, their molecular and functional differences have not been systematically characterized. This study established and analyzed paired PDC and PDO models derived from the same gastric cancer ascites to delineate platform-dependent molecular and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ascites
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to Multiomics

Share to Organoids

Share to Pleural Effusion, Malignant

Share to Proteomics

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 41942359
DOI: 10.5230/jgc.2026.26.e19
PMCID: PMC13053824

Genes

PDC
MET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric Cancer.PMID 41942359Read ↗

Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinomaSemantic proximity Read ↗

Xenograft and organoid models in developing precision medicine for gastric cancer (Review)Semantic proximity Read ↗

Human gastric cancer modelling using organoids.Semantic proximity Read ↗

Optimized large-scale longitudinal biorepository of gastroesophageal adenocarcinoma patient-derived organoids: High-fidelity models for personalized treatment to overcome resistanceSemantic proximity Read ↗

Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancerSemantic proximity Read ↗

Combining molecular characteristics and therapeutic analysis of PDOs predict clinical responses and guide PDAC personalized treatmentSemantic proximity Read ↗

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.Semantic proximity Read ↗

Precision Oncology at a Crossroads: How Organoid Platforms Are Reshaping the FieldSemantic proximity Read ↗

Ascites-Derived Organoids for Prediction of Treatment Response and Clinical Management in Ovarian Cancer: A Case ReportSemantic proximity Read ↗

The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidatesSemantic proximity Read ↗

Patient-derived organoids from malignant pleural effusion to explore for alternative therapies in thoracic tumorsSemantic proximity Read ↗

Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment ResponseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.